HUTCHMED (China) Ltd (HCM)

↓ Download CSV

CIK 0001648257 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9

In fiscal 2025, HUTCHMED (China) Ltd reported revenue of $548.51M, down 13.0% from the prior year. The company was profitable, with a net margin of 83.3%. It held $1.75B in total assets against $501.83M in total liabilities.

Key ratios (FY2025)

-7.1%
Operating margin
83.3%
Net margin
36.5%
Return on equity
-13.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$548.51M$630.20M$838.00M$426.41M$356.13M$227.98M$204.89M$214.11M$241.20M$216.08M
Cost of Revenue$336.35M$348.88M$384.45M$311.10M
Operating Income-$39.16M-$43.70M$18.38M-$407.69M-$328.32M-$196.67M-$146.39M-$92.64M-$53.42M-$46.70M
Net Income$456.91M$37.73M$100.78M-$360.83M-$194.65M-$125.73M-$106.02M-$74.81M-$26.74M$11.70M
EPS (Diluted)$0.52$0.04$0.12$-0.43$-0.25$-0.18$-0.16$-1.13$-0.43$0.20
Total Assets$1.75B$1.27B$1.28B$1.03B$1.37B$724.12M$465.12M$532.12M$597.93M$342.44M
Total Liabilities$501.83M$502.34M$536.39M$392.57M$333.15M$205.17M$152.22M$119.86M$112.97M$138.38M
Shareholders' Equity$1.25B$771.85M$743.39M$636.87M$1.04B$518.95M$312.90M$411.58M$483.88M$204.06M
Cash & Equivalents$71.33M$153.96M$283.59M$313.28M$377.54M$235.63M$121.16M$86.04M$85.27M$79.43M
Operating Cash Flow-$64.66M$497.0K$219.26M-$268.60M-$204.22M-$62.07M-$80.91M-$32.85M-$8.94M-$9.57M
Capital Expenditures$14.15M$17.93M$32.61M$36.66M$16.40M$7.95M$8.56M$6.36M$5.02M$4.33M
Shares Outstanding872.89M872.83M869.20M847.14M792.68M697.93M665.68M66.43M61.72M59.97M